Is Wockhardt a good stock to invest in?

Wockhardt is trading -3.08% lower at Rs 1,389.85 as compared to its last closing price. Wockhardt has been trading in the price range of 1,460.00 & 1,384.90. Wockhardt has given 237.83% in this year & 5.72% in the last 5 days.

The company posted a net profit of -22.00 Crores in its last quarter.

Listed peers of Wockhardt include JB Chemicals & Pharmaceuticals (-1.15%), Natco Pharma (0.27%), Wockhardt (-3.08%) etc.

Wockhardt has a 50.91% public holding.The Mutual Fund holding in Wockhardt was at 7.09% in 11 Nov 2024. The MF holding has increased from the last quarter. The FII holding in Wockhardt was at 6.61% in 11 Nov 2024. The FII holding has decreased from the last quarter.

1,389.85 -44.15 (-3.08%)Updated : Fri 6 Dec, 2024 | 15:59:48

Wockhardt share price range

Today's Low

1,384.90

Today's High

1,460.00

52 Week Low

328.20

52 Week High

1,467.00

Wockhardt share Key Metrics

Updated on 6 Dec 2024, 01:08 AM IST

Market Cap ( ₹ Cr.)

23,292.03

Beta	1.99
Div. Yield (%)	0.00
P/B	6.55
D/E	0.69
Open Price	1,449.70

TTM P/E	-
Peg. Ratio	-
Sector P/E	33.37
Prev. Close	1,434.00

WOCKPHARMA share Key metrics

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available

Bearish
Moderately Bearish
Neutral
Moderately Bullish
Bullish

Insight: Trends unavailable at the moment.

Wockhardt Financials

INCOME
BALANCE SHEET
Cashflow

Annual

Quarterly

Period	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Total Revenue	2,798.00	2,651.00	3,230.00	2,708.30
Selling/ General/ Admin Expenses Total	629.00	1,149.00	1,353.00	1,251.53
Depreciation/ Amortization	223.00	251.00	247.00	246.02
Other Operating Expenses Total	834.00	225.00	225.00	248.68
Total Operating Expense	2,944.00	2,972.00	3,362.00	3,157.37
Operating Income	-146.00	-321.00	-132.00	-449.07
Net Income Before Taxes	-420.00	-624.00	-411.00	-568.34
Net Income	-463.00	-559.00	-244.00	686.06
Diluted Normalized EPS	-25.53	-25.35	-10.37	-22.32

*All figures in crores except per share values

Detailed WOCKPHARMA Financials

Wockhardt forecast

Income Sheet (In Cr)Net Income Vs Revenue

Returns Metrics (In Cr)ROA Vs ROE

Mutual Fund Ownership

Ownership as on: Fri, 6 Dec, 2024

Samco Active Momentum Fund Regular Growth

Equity

Amount Invested (Cr.)80.12

% of AUM9.42%

ITI Focused Equity Fund Regular Growth

Equity

Amount Invested (Cr.)17.46

% of AUM3.51%

HDFC Pharma and Healthcare Fund Regular Growth

Equity

Amount Invested (Cr.)34.88

% of AUM2.52%

Mirae Asset Healthcare Fund Regular Growth

Equity

Amount Invested (Cr.)58.44

% of AUM2.11%

Tata India Pharma & Healthcare Fund Regular Growth

Equity

Amount Invested (Cr.)23.38

% of AUM1.93%

View All

Wockhardt Corporate actions

Board Meetings
AGM
Dividends
Bonus
Split
Rights

Meeting Date	Purpose
13-Nov-24	Quarterly Results
09-Aug-24	Quarterly Results
28-May-24	Audited Results
26-Mar-24	Others
14-Feb-24	Quarterly Results
14-Nov-23	Quarterly Results
14-Aug-23	Quarterly Results
26-May-23	Audited Results & Others
13-Feb-23	Quarterly Results
04-Nov-22	Quarterly Results

Meeting Date	Announcement On	Purpose
28-Jun-24	06-Jun-24	AGM
14-Aug-23	18-Jul-23	AGM
12-Aug-22	30-May-22	AGM
02-Aug-21	08-Jul-21	AGM

Announcement Date	Record Date	Ex-Rights Date	Ratio	FV	Description
06-Jan-22	09-Mar-22	08-Mar-22	3:10	5	Rights issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-.

Detailed WOCKPHARMA Corporate actions

Wockhardt Company profile

ABOUT Wockhardt

Industry Biotechnology & Drugs
ISIN INE049B01025
BSE Code 532300
NSE Code WOCKPHARMA

Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL TABLET, METHYCOBAL INJ, METHYCOBAL D, HAPID, PROXYFEN NANO GEL, LIVATIRA TABLET, LIVATIRA INJ, GABAWOK NT 100, GABAWOK NT 400, ETOBRIX 90, ETOBRIX TH4, ETOBRIX P, GLARZEN CARTRIDGE, GLARZEN DISPOPEN 2, ESOWOK D, TERITIDE, GLIMADAY, SITAWOK, GLARITUS, TRIMETADAY, MOPADAY, INOGLA, and ZINODAP. The Company has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.

Wockhardt Management

Habil Fakhruddin Khorakiwala Executive Chairman of the Board
Deepak Madnani Chief Financial Officer
Rashmi Mamtura Compliance Officer, Company Secretary
Murtaza Habil Khorakiwala Managing Director, Executive Director
Huzaifa Habil Khorakiwala Executive Director

FAQs about Wockhardt share price

Wockhardt is trading at 1389.85 as on Fri Dec 06 2024 10:29:48. This is -3.08% lower as compared to its previous closing price of 1434.00.

The market capitalization of Wockhardt is 23292.03 Cr as on Fri Dec 06 2024 10:29:48.

The 52 wk high for Wockhardt is 1467.00 whereas the 52 wk low is 328.20

Wockhardt can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 33.37
Dividend Yield: 0.00%
D/E ratio: 0.69

Wockhardt reported a net profit of -463.00 Cr in 2024.

Trending Stocks

Tata Motors share price

816.75+24.20(3.05%)

Axis Bank share price

1,186.05+18.75(1.61%)

Maruti Suzuki India share price

11,318.20+137.45(1.23%)

Bharti Airtel share price

1,597.00-16.30 (-1.01%)

Asian Paints share price

2,429.60-22.70 (-0.93%)

Home Markets Premium Instant Loan Mint Shorts

1 Week	5.72%
3 Months	31.64%
6 Month	162.85%
YTD	237.83%
1 Year	317.72%

Wockhardt share price

Wockhardt share price range

Wockhardt share Key Metrics

Wockhardt stock Analysis

Technical Trends

Long Term
Considers price movement over the last 6 months

Short Term
Considers price movement over the last 1-2 weeks

Wockhardt share price news

This multi-billion dollar opportunity could be a game changer for Wockhardt

Stocks to Watch: Vodafone Idea, Apollo Tyres, NBCC, NALCO, Dish TV, and more

Sebi's Buch pulls up a list of recusals amid allegations in ICICI, Mahindra cases

5 microcap stocks that India’s Warren Buffetts are betting on

“Baseless, misleading”: Wockhardt refutes allegations of rent payment by Carol Info to SEBI chief Madhabi Buch

Wockhardt Financials

Wockhardt forecast

Wockhardt Technical

Wockhardt Shareholding

Shareholding Pattern

Samco Active Momentum Fund Regular Growth

ITI Focused Equity Fund Regular Growth

HDFC Pharma and Healthcare Fund Regular Growth

Mirae Asset Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth

Wockhardt Corporate actions

Wockhardt Company profile

ABOUT Wockhardt

Wockhardt Management

FAQs about Wockhardt share price

Wockhardt Quick Links

Equity Quick Links

Wockhardt share price

Wockhardt share price range

Wockhardt share Key Metrics

Wockhardt stock Analysis

Long TermConsiders price movement over the last 6 months

Short TermConsiders price movement over the last 1-2 weeks

Wockhardt Financials

Wockhardt forecast

Wockhardt Technical

Wockhardt Shareholding

Shareholding Pattern

Wockhardt Corporate actions

Wockhardt Company profile

ABOUT Wockhardt

Wockhardt Management

FAQs about Wockhardt share price

Wockhardt Quick Links

Equity Quick Links

Wait for it…

Wait for it…

Long Term
Considers price movement over the last 6 months

Short Term
Considers price movement over the last 1-2 weeks